Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Lemeiter

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destructionGaëlle Clavel, Natacha Bessis, Delphine Lemeiter, et al.
Frontiers in Immunology|November 21, 2024
Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5Majda Lyna Mebrek, Tessnime Abaab, Delphine Lemeiter, et al.
Arthritis Research & Therapy|June 19, 2016
Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33Sara Khaleghparast Athari, Elodie Poirier, Jérôme Biton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental ArthritisJérôme Biton, Sara Khaleghparast Athari, Allan Thiolat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2019
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid ArthritisFrançois Santinon, Maxime Batignes, Majda Lyna Mebrek, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destructionGaëlle Clavel, Natacha Bessis, Delphine Lemeiter, et al.
Frontiers in Immunology|November 21, 2024
Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5Majda Lyna Mebrek, Tessnime Abaab, Delphine Lemeiter, et al.
Arthritis Research & Therapy|June 19, 2016
Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33Sara Khaleghparast Athari, Elodie Poirier, Jérôme Biton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2016
In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental ArthritisJérôme Biton, Sara Khaleghparast Athari, Allan Thiolat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2019
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid ArthritisFrançois Santinon, Maxime Batignes, Majda Lyna Mebrek, et al.
Pageof 2